SAN FRANCISCO, May 9, 2023 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2023. Cash and investments in marketable securities at March 31, 2023, were $456.8 million as compared to $505.0 million at December 31,...
News Ticker
- [ May 27, 2023 ] Senior Director, Head of Medical Affairs – Cargo Therapeutics – San Mateo, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Clinical Data Manager – Revolution Medicines – Redwood City, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Postdoc or Staff Computational Biologist: Quantitative Evolutionary Genomics and Ecology in Plants – Carnegie Institution – Stanford, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Research Assistant: Next Generation Sequencing and CRISPR in Plants – Carnegie Institution – Stanford, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Research Associate II, Analytical Development, Bioassays – Vir Biotechnology, Inc. – San Francisco, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
